Ads
related to: biogen stock price today
Search results
Why Biogen Stock Got Sick Today
Motley Fool· 10 months agoWhat happened Typically, when a publicly traded company reports an estimates-beating quarter, its stock price rises in reaction. There are always...
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Simply Wall St. via Yahoo Finance· 1 year agoBiogen's (NASDAQ:BIIB) stock is up by a considerable 12% over the past month. As most would know,...
Biogen Inc. (BIIB) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 10 months agoBiogen Inc. (BIIB) closed the most recent trading day at $276.17, moving -0.8% from the previous...
Biogen Inc.'s (NASDAQ:BIIB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The...
Simply Wall St. via Yahoo Finance· 9 months agoWith its stock down 14% over the past three months, it is easy to disregard Biogen (NASDAQ:BIIB)....
Biogen Inc.'s (NASDAQ:BIIB) Intrinsic Value Is Potentially 29% Above Its Share Price
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Biogen's estimated fair value is US$394 based on 2 Stage Free Cash Flow to Equity...
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations
Investor's Business Daily· 1 month agoTwo of Biogen's newest drugs, Leqembi and Skyclarys, walloped first-quarter sales expectations on...
Biogen Rises After 'Drama-Free' Panel Votes Unanimously In Support Of Alzheimer's Drug
Investor's Business Daily· 12 months agoBiogen stock drifted higher Monday after a panel of advisors to the Food and Drug Administration...
Is Biogen Inc (BIIB) Modestly Overvalued? A Comprehensive Valuation Analysis
GuruFocus.com via Yahoo Finance· 10 months agoBiogen Inc (NASDAQ:BIIB) experienced a daily gain of 2.32%, despite a 3-month loss of -11.75%. The...
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 1 month agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 4 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
